Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
deoxycholic acid
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:V03AX
|
| gptkbp:contraindication |
pregnancy
infection at injection site allergy to deoxycholic acid |
| gptkbp:form |
solution for injection
|
| gptkbp:indication |
double chin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:marketedAs |
gptkb:Belkyra
|
| gptkbp:marketedIn |
gptkb:Australia
gptkb:Canada gptkb:United_States |
| gptkbp:mechanismOfAction |
destroys fat cells
|
| gptkbp:otherName |
gptkb:ATX-101
|
| gptkbp:routeOfAdministration |
injection
|
| gptkbp:sideEffect |
pain
numbness redness swelling bruising hardness at injection site |
| gptkbp:usedFor |
reduction of submental fat
|
| gptkbp:bfsParent |
gptkb:Kythera_Biopharmaceuticals
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kybella
|